• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

接受静脉溶栓治疗的中国急性缺血性脑卒中患者出血性转化的危险因素:一项荟萃分析。

Risk factors of haemorrhagic transformation for acute ischaemic stroke in Chinese patients receiving intravenous thrombolysis: A meta-analysis.

作者信息

Wen Lihong, Zhang Song, Wan Kunzhen, Zhang Hong, Zhang Xiaoyun

机构信息

Hospital of Chengdu University of Traditional Chinese Medicine,Chengdu, Sichuan Province, P.R. China.

出版信息

Medicine (Baltimore). 2020 Feb;99(7):e18995. doi: 10.1097/MD.0000000000018995.

DOI:10.1097/MD.0000000000018995
PMID:32049794
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7035114/
Abstract

AIM

To determine the risk factors related to hemorrhagic transformation in Chinese patients with acute ischemic stroke treated with intravenous thrombolysis.

METHODS

Studies published in different languages were retrieved by systematically searching PubMed, EMBASE, Vip, CNKI, and WanFang Data from the establishment of the library to December 31, 2018, as well as manually examining the references of the original articles. The outcome measures of efficacy covered risk factors. Safety evaluation was measured by relative ratio of complications.

RESULTS

A total of 36 studies involving 5597 participants were covered in this meta-analysis. The results indicated that age [WMD = 2.44, 95% CI (1.39,3.48)], male [OR = 1.21, 95% CI (1.02, 1.44)], diabetes [OR = 2.05, 95%CI (1.72,2.44)], atrial fibrillation [OR = 2.85, 95%CI (2.40, 3.39)], previous stroke [OR = 1.8, 95%CI (1.33, 2.44)], onset to treatment time (OTT) [WMD = 3.74, 95%CI (2.91, 4.58)], National Institute of Health stroke scale scores (NIHSS) [WMD = 4.17, 95% CI (3.37, 4.97)], infarct size [WMD = 4.11, 95% CI (3.15, 5.37)], ischemic signs of computed tomography (CT) [OR = 3.49, 95%CI (2.47, 4.93)] were associated with increased risk of hemorrhagic transformation after intravenous thrombolysis.

CONCLUSION

The systematic review showed that male, age, diabetes, NIHSS, OTT, atrial fibrillation, post stroke, infarct size, and ischemic signs of CT were significantly correlated with hemorrhagic transformation (HT).

PROSPERO REGISTRATION NUMBER

CRD42019127499.

摘要

目的

确定接受静脉溶栓治疗的中国急性缺血性脑卒中患者发生出血性转化的相关危险因素。

方法

通过系统检索PubMed、EMBASE、维普、中国知网和万方数据(从建库至2018年12月31日)以及人工查阅原始文章的参考文献,检索不同语言发表的研究。疗效的结局指标涵盖危险因素。安全性评估通过并发症的相对比值来衡量。

结果

本荟萃分析共纳入36项研究,涉及5597名参与者。结果表明,年龄[加权均数差(WMD)=2.44,95%置信区间(CI)(1.39,3.48)]、男性[比值比(OR)=1.21,95%CI(1.02,1.44)]、糖尿病[OR=2.05,95%CI(1.72,2.44)]、心房颤动[OR=2.85,95%CI(2.40,3.39)]、既往卒中[OR=1.8,95%CI(1.33,2.44)]、发病至治疗时间(OTT)[WMD=3.74,95%CI(2.91,4.58)]、美国国立卫生研究院卒中量表评分(NIHSS)[WMD=4.17,95%CI(3.37,4.97)]、梗死灶大小[WMD=4.11,95%CI(3.15,5.37)]、计算机断层扫描(CT)的缺血征象[OR=3.49,95%CI(2.47,4.93)]与静脉溶栓后出血性转化风险增加相关。

结论

系统评价表明,男性、年龄、糖尿病、NIHSS、OTT、心房颤动、卒中后、梗死灶大小和CT的缺血征象与出血性转化(HT)显著相关。

国际前瞻性系统评价注册编号

CRD42019127499。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a309/7035114/0433c1140619/medi-99-e18995-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a309/7035114/0433c1140619/medi-99-e18995-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a309/7035114/0433c1140619/medi-99-e18995-g001.jpg

相似文献

1
Risk factors of haemorrhagic transformation for acute ischaemic stroke in Chinese patients receiving intravenous thrombolysis: A meta-analysis.接受静脉溶栓治疗的中国急性缺血性脑卒中患者出血性转化的危险因素:一项荟萃分析。
Medicine (Baltimore). 2020 Feb;99(7):e18995. doi: 10.1097/MD.0000000000018995.
2
Risk factors of haemorrhagic transformation for acute ischaemic stroke in Chinese patients receiving intravenous recombinant tissue plasminogen activator: a systematic review and meta-analysis.中国接受重组组织型纤溶酶原激活物静脉溶栓治疗的急性缺血性脑卒中患者发生出血性转化的风险因素:系统评价和荟萃分析。
Stroke Vasc Neurol. 2018 May 26;3(4):203-208. doi: 10.1136/svn-2018-000141. eCollection 2018 Dec.
3
Effect of intravenous thrombolysis in acute ischemic stroke patients with cerebral microbleeds and analysis of risk factors for hemorrhagic transformation.脑微出血急性缺血性脑卒中患者静脉溶栓的效果及出血转化的危险因素分析。
Eur Rev Med Pharmacol Sci. 2022 Feb;26(3):779-786. doi: 10.26355/eurrev_202202_27986.
4
Predictive model for the risk of hemorrhagic transformation after rt-PA intravenous thrombolysis in patients with acute ischemic stroke: A systematic review and meta-analysis.急性缺血性脑卒中患者静脉注射rt-PA溶栓后出血转化风险的预测模型:一项系统评价和荟萃分析。
Clin Neurol Neurosurg. 2024 Apr;239:108225. doi: 10.1016/j.clineuro.2024.108225. Epub 2024 Mar 7.
5
Analysis of Risk Factors Increased Hemorrhagic Transformation after Acute Ischemic Stroke.急性缺血性卒中后出血性转化风险因素分析
J Stroke Cerebrovasc Dis. 2018 Dec;27(12):3587-3590. doi: 10.1016/j.jstrokecerebrovasdis.2018.08.028. Epub 2018 Sep 12.
6
[Analysis of influencing factors of neurological function recovery and cerebral hemorrhage transformation after intravenous thrombolysis in patients with acute ischemic stroke].[急性缺血性脑卒中患者静脉溶栓后神经功能恢复及脑出血转化的影响因素分析]
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2020 Nov;32(11):1340-1345. doi: 10.3760/cma.j.cn121430-20200713-00517.
7
Perfusion computed tomography-guided intravenous thrombolysis for acute ischemic stroke beyond 4.5 hours: a case-control study.灌注 CT 引导下超 4.5 小时急性缺血性脑卒中静脉溶栓治疗:一项病例对照研究。
Cerebrovasc Dis. 2012;34(1):31-7. doi: 10.1159/000338778. Epub 2012 Jun 29.
8
A new nomogram for individualized prediction of the probability of hemorrhagic transformation after intravenous thrombolysis for ischemic stroke patients.一种新的列线图,用于个体化预测缺血性脑卒中患者静脉溶栓后出血转化的概率。
BMC Neurol. 2020 Nov 24;20(1):426. doi: 10.1186/s12883-020-02002-w.
9
[Impact of cerebral microbleeds on outcomes of acute ischemic stroke treated with intravenous thrombolysis].脑微出血对急性缺血性脑卒中静脉溶栓治疗结局的影响
Zhejiang Da Xue Xue Bao Yi Xue Ban. 2014 Jan;43(1):20-7. doi: 10.3785/j.issn.1008-9292.2014.01.019.
10
[Risk factors of hemorrhagic transformation in different locations and its relation to clinical outcomes of patients with acute ischemic stroke following intravenous thrombolysis].[急性缺血性卒中静脉溶栓后不同部位出血转化的危险因素及其与患者临床结局的关系]
Zhejiang Da Xue Xue Bao Yi Xue Ban. 2014 Jan;43(1):36-42. doi: 10.3785/j.issn.1008-9292.2014.01.021.

引用本文的文献

1
Factors influencing the health behaviors of patients with ischemic stroke from a social-ecological perspective: a cross-sectional study.从社会生态视角探讨影响缺血性脑卒中患者健康行为的因素:一项横断面研究
BMC Public Health. 2025 Aug 22;25(1):2890. doi: 10.1186/s12889-025-24167-0.
2
Piperine protects against cerebral ischemic injury by regulating the Caspase-1-mediated pyroptosis pathway.胡椒碱通过调节半胱天冬酶-1介导的细胞焦亡途径来预防脑缺血损伤。
Front Pharmacol. 2025 Jul 25;16:1601873. doi: 10.3389/fphar.2025.1601873. eCollection 2025.
3
Sex differences in outcomes and time to treatment in stroke patients treated with tenecteplase.

本文引用的文献

1
Increased perihematomal neuron autophagy and plasma thrombin-antithrombin levels in patients with intracerebral hemorrhage: An observational study.脑出血患者血肿周围神经元自噬及血浆凝血酶-抗凝血酶水平升高:一项观察性研究。
Medicine (Baltimore). 2019 Sep;98(39):e17130. doi: 10.1097/MD.0000000000017130.
2
Predictors of post-thrombolysis symptomatic intracranial hemorrhage in Chinese patients with acute ischemic stroke.中国急性缺血性脑卒中患者溶栓后症状性颅内出血的预测因素
PLoS One. 2017 Sep 18;12(9):e0184646. doi: 10.1371/journal.pone.0184646. eCollection 2017.
3
Heart Disease and Stroke Statistics-2016 Update: A Report From the American Heart Association.
接受替奈普酶治疗的中风患者的治疗结果和治疗时间的性别差异。
Eur Stroke J. 2025 Apr 16:23969873251332497. doi: 10.1177/23969873251332497.
4
Machine learning, clinical-radiomics approach with HIM for hemorrhagic transformation prediction after thrombectomy and treatment.机器学习,采用基于医院信息管理系统(HIM)的临床影像组学方法进行血栓切除术后出血转化预测及治疗。
Front Neurol. 2025 Feb 27;16:1471274. doi: 10.3389/fneur.2025.1471274. eCollection 2025.
5
Evaluating the interaction between hemorrhagic transformation and cerebral edema on functional outcome after ischemic stroke.评估缺血性脑卒中后出血性转化与脑水肿之间的相互作用对功能结局的影响。
J Stroke Cerebrovasc Dis. 2024 Oct;33(10):107913. doi: 10.1016/j.jstrokecerebrovasdis.2024.107913. Epub 2024 Aug 3.
6
Frequency, Severity, Risk Factors, and Outcome of Hemorrhagic Transformation in Anterior and Posterior Stroke.前后循环卒中出血性转化的发生率、严重程度、危险因素及预后
J Clin Med. 2024 Mar 29;13(7):2010. doi: 10.3390/jcm13072010.
7
The value of CT-based radiomics in predicting hemorrhagic transformation in acute ischemic stroke patients without recanalization therapy.基于CT的影像组学在预测未接受再通治疗的急性缺血性卒中患者出血性转化中的价值。
Front Neurol. 2024 Feb 1;15:1255621. doi: 10.3389/fneur.2024.1255621. eCollection 2024.
8
Analysis of influencing factors of hemorrhagic transformation in patients with large vessel occlusion stroke after mechanical thrombectomy.机械取栓术后大血管闭塞性卒中患者出血转化的影响因素分析
Am J Transl Res. 2023 Oct 20;15(10):6304-6313. eCollection 2023.
9
Prediction factors and clinical significance of different types of hemorrhagic transformation after intravenous thrombolysis.不同类型的静脉溶栓后出血性转化的预测因素及其临床意义。
Eur J Med Res. 2023 Nov 11;28(1):509. doi: 10.1186/s40001-023-01503-x.
10
Predictive role of pre-thrombolytic hs-CRP on the safety and efficacy of intravenous thrombolysis in acute ischemic stroke.hs-CRP 溶栓前预测急性缺血性脑卒中静脉溶栓的安全性及有效性。
BMC Neurol. 2023 Jun 23;23(1):244. doi: 10.1186/s12883-023-03291-7.
《2016年心脏病和中风统计数据更新:美国心脏协会报告》
Circulation. 2016 Jan 26;133(4):e38-360. doi: 10.1161/CIR.0000000000000350. Epub 2015 Dec 16.
4
Risk factors for intracranial hemorrhage in acute ischemic stroke patients treated with recombinant tissue plasminogen activator: a systematic review and meta-analysis of 55 studies.重组组织型纤溶酶原激活剂治疗急性缺血性脑卒中患者颅内出血的危险因素:55 项研究的系统评价和荟萃分析。
Stroke. 2012 Nov;43(11):2904-9. doi: 10.1161/STROKEAHA.112.665331. Epub 2012 Sep 20.
5
Stroke and stroke care in China: huge burden, significant workload, and a national priority.中国的中风和中风护理:巨大的负担、巨大的工作量和国家优先事项。
Stroke. 2011 Dec;42(12):3651-4. doi: 10.1161/STROKEAHA.111.635755. Epub 2011 Nov 3.
6
Hemorrhagic transformation of ischemic stroke: prediction with CT perfusion.缺血性卒中的出血性转化:CT灌注预测
Radiology. 2009 Mar;250(3):867-77. doi: 10.1148/radiol.2503080257.
7
Worldwide stroke incidence and early case fatality reported in 56 population-based studies: a systematic review.56项基于人群的研究报告的全球中风发病率和早期病死率:一项系统评价。
Lancet Neurol. 2009 Apr;8(4):355-69. doi: 10.1016/S1474-4422(09)70025-0. Epub 2009 Feb 21.
8
Risk of symptomatic intracerebral hemorrhage in patients treated with intra-arterial thrombolysis.接受动脉内溶栓治疗的患者发生症状性脑出血的风险。
Cerebrovasc Dis. 2009;27(4):368-74. doi: 10.1159/000202427. Epub 2009 Feb 16.
9
Pretreatment hemostatic markers of symptomatic intracerebral hemorrhage in patients treated with tissue plasminogen activator.接受组织型纤溶酶原激活剂治疗的有症状性脑出血患者的治疗前止血标志物。
Stroke. 2006 Apr;37(4):996-9. doi: 10.1161/01.STR.0000206461.71624.50. Epub 2006 Feb 23.
10
Association of outcome with early stroke treatment: pooled analysis of ATLANTIS, ECASS, and NINDS rt-PA stroke trials.早期卒中治疗与预后的关联:ATLANTIS、ECASS及NINDS rt-PA卒中试验的汇总分析
Lancet. 2004 Mar 6;363(9411):768-74. doi: 10.1016/S0140-6736(04)15692-4.